Roche(RHHBY) - 2024 Q1 - Earnings Call Presentation

Growth rates – from 31.12.2022 to 31.12.2023 (Total installed modules as of 31.12.2023) SWA=Serum Work Area 49 Accu-Chek SmartGuide CGM solution Enabling better decision-making for people with diabetes Accu-Chek SmartGuide CGM solution Improving diabetes management and care continuum • Data released at ATTD shows strong performance of first Roche CGM • 14 days of reliable and accurate real-time glucose sensor data • Predictive algorithms for 2 hours and night-time hypo • Addressing the needs of T1D and T2D ...